Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-29

Clinical Trial Update: Safety and Tolerability of StroMel™ in Subjects with Moderate to Severe Osteoarthritis of the Knee Joint [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial examining the safety and tolerability of StroMel in adults with moderate to severe knee osteoarthritis; the study is not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • StroMel

Snippet

Sponsor: Akan Biosciences, LLC | Conditions: Osteo Arthritis Knee | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING